[1]
V., A.N., JOHN, A., P. R, S., PRIYA, S., RAVIRAJ, C. and ASHTEKAR, .H. 2024. OPTIMIZED SOLID LIPID NANOPARTICLES FOR ENHANCED ORAL BIOAVAILABILITY AND OSTEOGENIC EFFECT OF IPRIFLAVONE: FORMULATION, CHARACTERIZATION, AND IN VITRO EVALUATION. International Journal of Applied Pharmaceutics. 16, 6 (Sep. 2024). DOI:https://doi.org/10.22159/ijap.2024v16i6.51890.